الصيدلة السريرية

منشورات ٢٠١٨ - ٢٠١٩

1- Shaimaa. M. Nashat et al. Effectiveness of vitamin D in monitoring of pediatric hypertension: Systematic review and meta-analysis. Int. Res. J. Pharm. 2018;9(7):85-88 http://dx.doi.org/10.7897/2230-8407.097130.

 

2- Shaimaa. M. Nashat et al. Attitude, believes and decision of practitioners associated with complementary and alternative therapy in the treatment of pediatric population. Int. Res. J. Pharm. 2018;9(7):126-130 http://dx.doi.org/10.7897/2230-8407.097136.

 

3- Mohamed. M. Gamaleldin et al. Use of soft drinks and risk of osteoporosis: A systematic review. Int. Res. J. Pharm.2018;9(10):1-4 http://dx.doi.org/10.7897/2230-8407.0910216.

 

4- Sahibzada, M. U. K., Sadiq, A., Faidah, H. S., Khurram, M., Amin, M. U., Haseeb, A., & Kakar, M. (2018). Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity. Drug design, development and therapy, 12, 303.

 

5- Almarzoky Abuhussain SS, Burak MA, Adams DK, Kohman KN, Tart SB, Hobbs ALV, Jacknin G, Nailor MD, Keyloun KR, Nicolau DP, Kuti JL. Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education. Open Forum Infect Dis. 2018 Oct 8;5(10):ofy206. doi: 10.1093/ofid/ofy206. eCollection 2018 Oct.

 

6- Almarzoky Abuhussain SS, Kuti JL, Nicolau DP. Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00113-18. doi: 10.1128/AAC.00113-18. Print 2018 Jul.

 

7- Almarzoky Abuhussain SS, Goodlet KJ, Nailor MD, Nicolau DP. Optimizing skin and skin structure infection outcomes: considerations of cost of care. Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):235-244. doi: 10.1080/14737167.2018.1450142. Epub 2018 Mar 14. Review.

 

8- Rico Caballero V, Almarzoky Abuhussain S, Kuti JL, Nicolau DP. Efficacy of Human-Simulated Exposures of Ceftolozane-Tazobactam Alone and in Combination with Amikacin or Colistin against Multidrug-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model. Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02384-17. doi: 10.1128/AAC.0238417. Print 2018 May.

 

9- Monogue ML, Almarzoky Abuhussain SS, Kuti JL, Nicolau DP. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health Syst Pharm. 2018 Jan 1;75(1):e36-e44. doi: 10.2146/ajhp170123.

 

10- Almarzoky Abuhussain SS, Avery LM, Abdelraouf K, Nicolau DP. 2018. In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures Against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model. Antimicrob Agents Chemother, Antimicrobial Agents and Chemotherapy Dec 2018, 63 (1) e01931-18; DOI: 10.1128/AAC.01931-18.

 

11- Almarzoky Abuhussaina SS; Sutherland CA, Nicolau DP. In vitro Potency of Ceftolozane/Tazobactam and Other Antipseudomonal β-lactams Against P. aeruginosa.IDweek 2018 San Francisco, CA. Abstr 2175.

 

12- Almarzoky Abuhussaina SS; Sutherland CA, Nicolau DP. Single β-lactams v. Combination Regimens: Assessing the Probability that an Active Agent Would be Selected When Considering Empiric Therapy for P. aeruginosa. IDweek 2018 San Francisco, CA. Abstr 2176.

 

13- Almarzoky Abuhussain SS, Burak MA, Adams DK, Kohman KN, Tart SB, Hobbs ALV, Jacknin G, Nailor MD, Keyloun KR, Nicolau DP, Kuti JL. Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department. BMC Health Serv Res. 2018 Dec 4;18(1):932. doi: 10.1186/s12913-018-3751-0.

 

14- Kamilia Abdelraouf; Safa S. Almarzoky Abuhussain; David P Nicolau. Efficacy of the Human-Simulated Regimen (HSR) of Cefepime (FEP)/VNRX-5133 Combination Against Serine β-Lactamase-Producing Gram-negative Bacteria in the Neutropenic Murine Thigh Infection Model. ECCMID 2019 Amsterdam, Netherlands. Abstr 2887.

 

15- Almangour TA, Perry GK, Terriff CM, Alhifany AA, Kaye KS. Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility. Diagn Microbiol Infect Dis. 2018.

 

16- Alhindi et al. (2019). Low Citrate Synthase Activity Is Associated with Glucose Intolerance and Lipotoxicity. Hindawi Journal of Nutrition and Metabolism Volume 2019, 14

 

17- ME Elrggal, M Al-Muwallad, A Al-Otaibi, J Alsiddik, A Shahbar, E Cheema. Assessment of quality of reporting of Helicobacter pylori related randomized controlled trials: a focus on highly ranked gastroenterology journals. International Journal of Clinical Trials 5 (1), 21-29

 

18- MA Hadi, M Ali, A Haseeb, MMA Mohamed, ME Elrggal. Impact of test anxiety on pharmacy students’ performance in Objective Structured Clinical Examination: a cross‐sectional survey. International Journal of Pharmacy Practice 26 (2), 191-194

 

19- Hani Faidah, Abdul Haseeb H, ME Elrggal. Parents’ self-directed practices towards the use of antibiotics for upper respiratory tract infections in Makkah, Saudi Arabia BMC Pediatrics 201919:46.

 

2017-2018 Publications

 

1. Hadi, M. A., Ali, M., Haseeb, A., Mohamed, M. M., Elrggal, M. E., & Cheema, E. (2018). Impact of test anxiety on pharmacy students’ performance in Objective Structured Clinical Examination: a cross‐sectional survey. International Journal of Pharmacy Practice, 26(2), 191-194.

 

2. Cheema, E. The Need to Introduce Simulation-Based Teaching in Pharmacy Education in Saudi Arabia. Pharmacy (Basel). 2018 Jul 3;6(3).

 

3. Cheema E, Sutcliffe P and Singer DRJ: Gaining insight into patient’s medications and their self-reported experience of adverse drug reactions: A cross sectional study in the emergency department. Int J Pharm Sci Res 2018; 9(5): 2067-72.doi: 10.13040/IJPSR.0975-8232.9(5).2067-72.

 

4. Cheema, E., Haseeb, A., Khan, T. M., Sutcliffe, P., & Singer, D. R. (2017). Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom. Pharmacy Practice (Granada), 15(3).

 

5. Al-Gethamy, M. M., Faidah, H. S., Ademola, H. A., Haseeb, A., Ashgar, S. S., Mohanned, T. K., ... & Hassali, M. A. (2017). Risk factors associated with multi-drug-resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia-a matched case–control study. Journal of International Medical Research, 0300060517706284.

 

6. E Cheema, FK Alhomoud, ASALD Kinsara, J Alsiddik, MH Barnawi, ME Elrggal. The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials. PloS one 13 (3), e0193510

 

7. ME Elrggal, M Al-Muwallad, A Al-Otaibi, J Alsiddik, A Shahbar, E Cheema . Assessment of quality of reporting of Helicobacter pylori related randomized controlled trials: a focus on highly ranked gastroenterology journals. International Journal of Clinical Trials 5 (1), 21-29

 

8. ME Elrggal, NA Karami, B Rafea, L Alahmadi, A Al Shehri, R Alamoudi Evaluation of preparedness of healthcare student volunteers against Middle East respiratory syndrome coronavirus (MERS-CoV) in Makkah, Saudi Arabia: a cross-sectional study, Journal of Public Health, 1-6

 

9. Imran Shahid, Munjed Mahmoud Ibrahim, Muhammad Usman Nawaz, Mohammad Tarque Imam and Waleed H. AlMalki (June 20th 2018). Resistance-Associated Substitutions/Variants Correlate to Therapeutic Outcomes of Novel Direct-Acting Antivirals in Different HCV Genotype Treated Individuals, Genotyping Ibrokhim Abdurakhmonov, IntechOpen, DOI: 10.5772/intechopen.76395.

 

10. Parents' Self-Directed Practices towards the use of Antibiotics for Upper Respiratory Tract Infections in Makkah, Saudi Arabia. BMC Pediatrics (under Final Editorial review).

 

11. Development and validation of a novel General Medication Adherence Scale (GMAS) for chronic illness patients in Pakistan Manuscript ID: 345252 Authors:  Atta Abbas Naqvi, Mohamed Azmi Hassali, Mehwish Rizvi, Ale Zehra, Wajiha Iffat, Abdul Haseeb, Shazia Jamshed Journal: Frontiers in Pharmacology, section Pharmaceutical Medicine and Outcomes Research (Accepted for publication)